ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000260349.1	Nilotinib	Breast invasive carcinoma	0.013091479	Resistant
ENSG00000260349.1	Nilotinib	Stomach adenocarcinoma	0.04126981	Sensitive